RADIATION THERAPY ONCOLOGY GROUP
RTOG 0615
A PHASE II STUDY OF CONCURRENT CHEMORADIOTHERAPY USING THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY (3D CRT) OR INTENSITY-MODULATED RADIATION THERAPY (IMRT) + BEVACIZUMAB (BV) FOR LOCALLY OR REGIONALLY ADVANCED NASOPHARYNGEAL CANCER
RTOG 0615
A PHASE II STUDY OF CONCURRENT CHEMORADIOTHERAPY USING THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY (3D CRT) OR INTENSITY-MODULATED RADIATION THERAPY (IMRT) + BEVACIZUMAB (BV) FOR LOCALLY OR REGIONALLY ADVANCED NASOPHARYNGEAL CANCER
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Facility Questionnaire: Part I is required for this protocol.
- Dry Run Guidelines (from RTOG 0225)
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- Data Submission Checklist
- ATC Compliant Treatment Planning Systems
- QA Scoring Criteria (1/26/07)
- Structure Names
- Neck Node Atlas
- Protocol Text (http://www.rtog.org/)
Back to protocols
